Venki Ramakrishnan shared the 2009 Nobel Prize in Chemistry for ribosome structure work, served as President of the Royal Society (2015-2020), and authored 'Why We Die: The New Science of Aging and the Quest for Immortality'.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
While AlphaFold revolutionized protein structure prediction, translating AI insights into actual treatments requires navigating the analog world of clinical trials, manufacturing, and regulation — a far slower process than digital innovation.
Altos Labs has hired top scientists with massive funding ($5B) to pursue cellular reprogramming, but the approach faces major hurdles: heterogeneous reprogramming in tissues, oncogene risks, delivery challenges, and unproven lifespan extension even in mice.